PuSH - Publikationsserver des Helmholtz Zentrums München

Zeitschriften-Browsing

129 Datensätze gefunden.
Zum Exportieren der Ergebnisse bitte einloggen.
▮◀ ◀◀ 1 ... 2 ... 3 ... 4 ... 5 ... 6 ... 7 ... ▶▶ ▶▮
Alle Publikationen dieser Seite in den Korb legen
61.
Jochmann, R.* et al.: O-linked N-acetylglucosaminylation of Sp1 inhibits the human immunodeficiency virus type 1 promoter. J. Virol. 83, 3704-3718 (2009)
62.
Kindsmüller, K.* et al.: A 49-kilodalton isoform of the adenovirus type 5 early region 1B 55-kilodalton protein is sufficient to support virus replication. J. Virol. 83, 9045-9056 (2009)
63.
Lehmann, M.H. et al.: Modified vaccinia virus ankara triggers chemotaxis of monocytes and early respiratory immigration of leukocytes by induction of CCL2 expression. J. Virol. 83, 2540-2552 (2009)
64.
Pairan, A.* & Bruß, V.: Functional surfaces of the hepatitis B virus capsid. J. Virol. 83, 11616-11623 (2009)
65.
Schön, U. et al.: Human endogenous retroviral long terminal repeat sequences as cell type-specific promoters in retroviral vectors. J. Virol. 83, 12643-12650 (2009)
66.
Adhikary, D. ; Behrends, U. ; Feederle, R.* ; Delecluse, H.J.* & Mautner, J.: Standardized and highly efficient expansion of Epstein-Barr virus-specific CD4+ T cells by using virus-like particles. J. Virol. 82, 3903-3911 (2008)
67.
Frank, O.* et al.: Variable transcriptional activity of endogenous retroviruses in human breast cancer. J. Virol. 82, 1808-1818 (2008)
68.
le Clorennec, C.* et al.: Molecular basis of cytotoxicity of Epstein-Barr virus (EBV) latent membrane protein 1 (LMP1) in EBV latency III B cells: LMP1 induces type II ligand-independent autoactivation of CD95/Fas with caspase 8-mediated apoptosis. J. Virol. 82, 6721-6733 (2008)
69.
Lindner, S.E.* ; Zeller, K. ; Schepers, A. & Sugden, B.*: The affinity of EBNA1 for its origin of DNA synthesis is a determinant of the origin's replicative efficiency. J. Virol. 82, 5693-5702 (2008)
70.
Sander, G.* et al.: Intracellular localization map of human herpesvirus 8 proteins. J. Virol. 82, 1908-1922 (2008)
71.
Adler, H. ; Steer, B. ; Freimüller, K. & Haas, J.*: Murine Gammaherpesvirus 68 Contains Two Functional Lytic Origins of Replication. J. Virol. 81, 7300-7305 (2007)
72.
Boccellato, F.* et al.: EBNA2 Interferes with the Germinal Center Phenotype by Downregulating BCL6 and TCL1 in Non-Hodgkin's Lymphoma Cells. J. Virol. 81, 2274-2282 (2007)
73.
Gasteiger, G. ; Kastenmüller, W.* ; Ljapoci, R. ; Sutter, G.* & Drexler, I.: Cross-priming of cytotoxic T cells dictates antigen requisites for modified vaccinia virus ankara vector vaccines. J. Virol. 81, 11925-11936 (2007)
74.
Tierney, R.* et al.: Epstein-Barr virus exploits BSAP/Pax5 to achieve the B-cell specificity of its growth-transforming program. J. Virol. 81, 10092-10100 (2007)
75.
Feederle, R.* et al.: Epstein-barr virus BNRF1 protein allows efficient transfer from the endosomal compartment to the nucleus of primary B lymphocytes. J. Virol. 80, 9435-9443 (2006)
76.
Goormachtigh, G.* et al.: Autoactivation of the Epstein-barr virus oncogenic protein LMP1 during type II latency through opposite roles of the NF-kB and JNK signaling pathways. J. Virol. 80, 7382-7393 (2006)
77.
Maier, S. et al.: Cellular target genes of Epstein-Barr virus nuclear antigen 2. J. Virol. 80, 9761-9771 (2006)
78.
Milosevic, S. ; Behrends, U. ; Adhikary, D. & Mautner, J.: Identification of major histocompatibility complex class II-restricted antigens and epitopes of the Epstein-barr virus by a novel bacterial expression cloning approach. J. Virol. 80, 10357-10364 (2006)
79.
Pegman, P.M.* et al.: Epstein-Barr virus nuclear antigen 2 trans-activates the cellular antiapoptotic bfl-1 gene by a CBF1/RBPJk-dependent pathway. J. Virol. 80, 8133-8144 (2006)
80.
Stengel, A. et al.: Expression profiles of endogenous in Old World Monkeys. J. Virol. 80, 4415-4421 (2006)
▮◀ ◀◀ 1 ... 2 ... 3 ... 4 ... 5 ... 6 ... 7 ... ▶▶ ▶▮